Showing results (11-20 of 102) with videos related to
Sort By:
Pageof 11
Cold Spring Harbor Perspectives in Biology|July 19, 2017
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in CancerJuming Yan, Mark J Smyth, Michele W L TengGenome Medicine|October 27, 2016
Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?Jake S O'Donnell, Mark J Smyth, Michele W L TengTrends in Immunology|August 20, 2013
A balance of interleukin-12 and -23 in cancerShin Foong Ngiow, Michele W L Teng, Mark J SmythNature Reviews. Clinical Oncology|December 8, 2018
Cancer immunoediting and resistance to T cell-based immunotherapyJake S O'Donnell, Michele W L Teng, Mark J SmythCancer Research|October 20, 2011
Prospects for TIM3-Targeted Antitumor ImmunotherapyShin Foong Ngiow, Michele W L Teng, Mark J SmythCancer Cell|December 17, 2011
Stable IL-10: a new therapeutic that promotes tumor immunityMichele W L Teng, Phillip K Darcy, Mark J SmythNature Reviews. Cancer|October 24, 2017
Targeting immunosuppressive adenosine in cancerDipti Vijayan, Arabella Young, Michele W L Teng, et al.Seminars in Cancer Biology|May 4, 2017
PI3K-AKT-mTOR inhibition in cancer immunotherapy, reduxJake S O'Donnell, Daniela Massi, Michele W L Teng, et al.Cancer Research|May 16, 2015
Classifying Cancers Based on T-cell Infiltration and PD-L1Michele W L Teng, Shin Foong Ngiow, Antoni Ribas, et al.Nature Reviews. Clinical Oncology|November 25, 2015
Combination cancer immunotherapies tailored to the tumour microenvironmentMark J Smyth, Shin Foong Ngiow, Antoni Ribas, et al.Pageof 11